Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaobo Hu

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Current Medical Imaging|April 30, 2026
Intrahepatic Splenosis Mimicking Hepatocellular Carcinoma: A Case Series of Eleven PatientsSuzhen Li, Tianhao Zou, Zhiying Wang, et al.
International Journal of Molecular Sciences|December 9, 2023
FARSB Facilitates Hepatocellular Carcinoma Progression by Activating the mTORC1 Signaling PathwayYaofeng Wang, Gengqiao Wang, Shaobo Hu, et al.
International Journal of Biological Macromolecules|May 26, 2017
MiR-221 mediates the epithelial-mesenchymal transition of hepatocellular carcinoma by targeting AdipoR1Tong Li, Min Li, Shaobo Hu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 18, 2019
PI3Kγ (Phosphoinositide 3-Kinase γ) Regulates Vascular Smooth Muscle Cell Phenotypic Modulation and Neointimal Formation Through CREB (Cyclic AMP-Response Element Binding Protein)/YAP (Yes-Associated Protein) SignalingQihong Yu, Wei Li, Rong Jin, et al.
Journal of Nanobiotechnology|October 31, 2021
Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinomaJianjun Xu, Qichang Zheng, Xiang Cheng, et al.
BBA Advances|May 29, 2026
Lysosomal membrane permeabilization is involved in CYP2E1-induced apoptosis in hepatocellular carcinoma cellsXuan Wang, An Wang, Huanhuan He, et al.
Molecular Medicine (Cambridge, Mass.)|June 6, 2024
CYP2E1 deficit mediates cholic acid-induced malignant growth in hepatocellular carcinoma cellsZhiwei Hao, Xuemin Liu, Huanhuan He, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 5, 2024
Necroptosis-Mediated Synergistic Photodynamic and Glutamine-Metabolic Therapy Enabled by a Biomimetic Targeting Nanosystem for CholangiocarcinomaQichang Zheng, Tianhao Zou, Weimin Wang, et al.
Frontiers in Cardiovascular Medicine|November 18, 2024
Global, regional, and national time trends in ischaemic heart disease incidence over three decades (1990-2019): an age-period-cohort analysis of the global burden of disease study 2019Juan Tang, Shaobo Hu, Xiaozhu Liu, et al.
Nanomedicine (London, England)|November 30, 2019
Biodistribution and biocompatibility of glycyrrhetinic acid and galactose-modified chitosan nanoparticles as a novel targeting vehicle for hepatocellular carcinomaMin Li, Yan Wang, Shuai Jiang, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Current Medical Imaging|April 30, 2026
Intrahepatic Splenosis Mimicking Hepatocellular Carcinoma: A Case Series of Eleven PatientsSuzhen Li, Tianhao Zou, Zhiying Wang, et al.
International Journal of Molecular Sciences|December 9, 2023
FARSB Facilitates Hepatocellular Carcinoma Progression by Activating the mTORC1 Signaling PathwayYaofeng Wang, Gengqiao Wang, Shaobo Hu, et al.
International Journal of Biological Macromolecules|May 26, 2017
MiR-221 mediates the epithelial-mesenchymal transition of hepatocellular carcinoma by targeting AdipoR1Tong Li, Min Li, Shaobo Hu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 18, 2019
PI3Kγ (Phosphoinositide 3-Kinase γ) Regulates Vascular Smooth Muscle Cell Phenotypic Modulation and Neointimal Formation Through CREB (Cyclic AMP-Response Element Binding Protein)/YAP (Yes-Associated Protein) SignalingQihong Yu, Wei Li, Rong Jin, et al.
Journal of Nanobiotechnology|October 31, 2021
Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinomaJianjun Xu, Qichang Zheng, Xiang Cheng, et al.
BBA Advances|May 29, 2026
Lysosomal membrane permeabilization is involved in CYP2E1-induced apoptosis in hepatocellular carcinoma cellsXuan Wang, An Wang, Huanhuan He, et al.
Molecular Medicine (Cambridge, Mass.)|June 6, 2024
CYP2E1 deficit mediates cholic acid-induced malignant growth in hepatocellular carcinoma cellsZhiwei Hao, Xuemin Liu, Huanhuan He, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 5, 2024
Necroptosis-Mediated Synergistic Photodynamic and Glutamine-Metabolic Therapy Enabled by a Biomimetic Targeting Nanosystem for CholangiocarcinomaQichang Zheng, Tianhao Zou, Weimin Wang, et al.
Frontiers in Cardiovascular Medicine|November 18, 2024
Global, regional, and national time trends in ischaemic heart disease incidence over three decades (1990-2019): an age-period-cohort analysis of the global burden of disease study 2019Juan Tang, Shaobo Hu, Xiaozhu Liu, et al.
Nanomedicine (London, England)|November 30, 2019
Biodistribution and biocompatibility of glycyrrhetinic acid and galactose-modified chitosan nanoparticles as a novel targeting vehicle for hepatocellular carcinomaMin Li, Yan Wang, Shuai Jiang, et al.
Pageof 6